Omalizumab could be effective in children with severe eosinophilic non-allergic asthma

Pediatr Allergy Immunol. 2018 Feb;29(1):90-93. doi: 10.1111/pai.12813. Epub 2017 Nov 20.

Authors

M Bourgoin-Heck^{1

2

3}, F Amat^{1

2

3}, C Trouvé¹, A Bernard¹, J-P Magny¹, N Lambert^{1

2

3}, J Just^{1

2

3}

Affiliations

¹ Department of Allergology-Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand Trousseau, Assistance Publique-Hôpitaux de Paris, Paris, France.
² UPMC Univ Paris 06, Sorbonne Universités, Paris, France.
³ Equipe EPAR, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR_S1136, INSERM, Paris, France.

PMID: 28981968
DOI: 10.1111/pai.12813

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Child
Eosinophilia / complications
Female
Humans
Male
Omalizumab / therapeutic use*
Treatment Outcome

Substances

Anti-Asthmatic Agents
Omalizumab